(S (NP (NP (NP (NN Background)) (: :) (NP (NP (DT An) (VBG increasing) (NN volume)) (PP (IN of) (NP (NN prostate) (NNS biopsies))))) (CC and) (NP (NP (DT a) (ADJP (NN world) (HYPH -) (JJ wide)) (NN shortage)) (PP (IN of) (NP (NN uro) (HYPH -) (NNS pathologists))))) (VP (VBZ puts) (NP (NP (DT a) (NN strain)) (PP (IN on) (NP (NN pathology) (NNS departments))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (NP (DT the) (JJ high) (ADJP (AFX intra) (HYPH -) (CC and) (NN inter-observer)) (NN variability)) (PP (IN in) (NP (NN grading)))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NML (PP (IN over) (HYPH -) (PP (CC and) (PP (NP (NN undertreatment)) (IN of))))) (NN prostate) (NN cancer))))) (. .))
(S (NP (NNP Artificial) (NML (NN intelligence) (-LRB- -LRB-) (NN AI) (-RRB- -RRB-)) (NNS methods)) (VP (MD may) (VP (VB alleviate) (NP (DT these) (NNS problems)) (PP (IN by) (S (VP (VBG assisting) (NP (NNS pathologists)) (S (VP (TO to) (VP (VP (VB reduce) (NP (NN workload))) (CC and) (VP (VB harmonize) (NP (NN grading))))))))))) (. .))
(FRAG (NP (NNS Methods)) (: :) (S (NP (PRP We)) (VP (VBD digitized) (NP (CD 6,682) (NN needle) (NNS biopsies)) (PP (IN from) (NP (CD 976) (NNS participants))) (PP (IN in) (NP (NP (DT the) (NN population)) (VP (VBN based) (NP (NNP STHLM3) (JJ diagnostic) (NN study) (S (VP (TO to) (VP (VB train) (NP (JJ deep) (JJ neural) (NNS networks)) (PP (IN for) (S (VP (VBG assessing) (NP (NN prostate) (NNS biopsies)))))))))))))) (. .))
(S (NP (DT The) (NNS networks)) (VP (VBD were) (VP (VBN evaluated) (PP (IN by) (S (VP (VBG predicting) (NP (NP (DT the) (NN presence)) (, ,) (NP (NN extent)) (, ,) (CC and) (NP (NP (NNP Gleason) (NN grade)) (PP (IN of) (NP (JJ malignant) (NN tissue))))) (PP (IN for) (NP (NP (DT an) (JJ independent) (NN test)) (VP (VBN set) (S (VP (VBG comprising) (NP (CD 1,631) (NNS biopsies)) (PP (IN from) (NP (CD 245) (NNS men))))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB additionally)) (VP (VBD evaluated) (S (VP (VBG grading) (NP (NN performance)) (PP (IN on) (NP (NP (CD 87) (NNS biopsies)) (VP (ADVP (RB individually)) (VBN graded) (PP (IN by) (NP (CD 23) (JJ experienced) (JJ urological) (NNS pathologists))) (PP (IN from) (NP (NP (DT the) (NNP International) (NNP Society)) (PP (IN of) (NP (NNP Urological) (NNP Pathology))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD assessed) (NP (JJ discriminatory) (NN performance)) (PP (IN by) (NP (NP (NN receiver) (NN operating) (NNS characteristics) (PRN (-LRB- -LRB-) (NP (NNP ROC)) (-RRB- -RRB-))) (CC and) (NP (NML (NN tumor) (NN extent)) (NNS predictions)))) (PP (IN by) (S (VP (VBG correlating) (NP (VBN predicted) (NML (ADJP (NN millimeter) (NN cancer)) (NN length))) (PP (IN against) (NP (NNS measurements))) (PP (IN by) (NP (DT the) (NN reporting) (NN pathologist))))))) (. .))
(S (NP (PRP We)) (VP (VBD quantified) (NP (NP (DT the) (NN concordance)) (PP (IN between) (NP (NP (NNS grades)) (VP (VBN assigned) (PP (IN by) (NP (NP (DT the) (NN AI)) (CC and) (NP (NP (DT the) (NN expert)) (NP (JJ urological) (NNS pathologists))))) (S (VP (VBG using) (NP (NP (NNP Cohen) (POS 's)) (NN kappa))))))))) (. .))
(S (NP (NP (NP (NNS Results)) (: :) (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (NN AI) (S (VP (TO to) (VP (VB detect)))))))) (CC and) (NP (NP (NN grade) (NN cancer)) (PP (IN in) (NP (NN prostate) (NN needle) (NN biopsy) (NNS samples))))) (VP (VBD was) (ADJP (JJ comparable) (PP (IN to) (NP (NP (DT that)) (PP (IN of) (NP (JJ international) (NNS experts)))))) (PP (IN in) (NP (NN prostate) (NN pathology)))) (. .))
(S (NP (DT The) (NN AI)) (VP (VBD achieved) (NP (DT an) (NN area)) (PP (IN under) (NP (NP (DT the) (NNP ROC) (NN curve)) (PP (IN of) (NP (NP (NP (CD 0.997)) (PP (IN for) (S (VP (VBG distinguishing) (PP (IN between) (NP (ADJP (JJ benign) (CC and) (JJ malignant)) (NN biopsy) (NNS cores))))))) (, ,) (CC and) (NP (NP (CD 0.999)) (PP (IN for) (S (VP (VBG distinguishing) (PP (IN between) (NP (NNS men))) (PP (IN with) (CC or) (IN without) (NP (NN prostate) (NN cancer)))))))))))) (. .))
(S (NP (NP (DT The) (NN correlation)) (PP (IN between) (NP (NP (NN millimeter) (NN cancer)) (VP (VP (VBN predicted) (PP (IN by) (NP (DT the) (NN AI)))) (CC and) (VP (VBN assigned) (PP (IN by) (NP (DT the) (NN reporting) (NN pathologist)))))))) (VP (VBD was) (NP (CD 0.96))) (. .))
(S (PP (IN For) (S (VP (VBG assigning) (NP (NN Gleason) (NNS grades))))) (, ,) (NP (DT the) (NN AI)) (VP (VBD achieved) (NP (NP (DT an) (JJ average) (JJ pairwise) (NN kappa)) (PP (IN of) (NP (CD 0.62))))) (. .))
(S (NP (DT This)) (VP (VBD was) (PP (IN within) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (DT the) (VBG corresponding) (NNS values)) (PP (IN for) (NP (DT the) (NN expert) (NNS pathologists))))))) (PRN (-LRB- -LRB-) (NP (NP (CD 0.60)) (PP (IN to) (NP (CD 0.73)))) (-RRB- -RRB-))) (. .))
